Atrial fibrillation (AF) and heart failure (HF) are two cardiovascular diseases with an
increasing prevalence worldwide. These conditions share common pathophysiologiesand …

Background Consideration of circulating biomarkers for risk stratification in heart failure (HF)
is recommended, but the influence of atrial fibrillation (AF) on prognostic performance of …

Atrial fibrillation and heart failure are both associated with increased morbidity as well as
mortality, and there is a complex interaction between the two conditions. The increasing …

Heart failure (HF) and atrial fibrillation (AF) demonstrate a constantly increasing prevalence
during the 21 st century worldwide, as a result of the aging population and the successful …

Atrial fibrillation (AF) and congestive heart failure (CHF) are commonly encountered
together, either condition predisposing to the other. The presence of each condition …

Heart failure (HF) and atrial fibrillation (AF) are two growing epidemics associated with
significant morbidity and mortality. They often coexist due to common risk factors and shared …

Thus, a question spontaneously arises: would a biomarker really change the daily
management of AF patients? While research on biomarkers certainly contributes to un‑cover …

Atrial fibrillation (AF) and heart failure (HF) are chronic cardiovascular conditions that
continue to increase in prevalence worldwide and have been described as global …

Heart failure (HF) and atrial fibrillation (AF) are cardiovascular diseases that have a
continuously increasing prevelance and both often coexist. The presence of AF in HF …

Aims The clinical correlates and consequences of atrial fibrillation (AF) might be different
between heart failure with reduced vs. preserved ejection fraction (HFrEF vs. HFpEF) …